Global Biopharmaceutical Oral Drug Delivery Market Insights and Forecast to 2031

Report ID: 1563839 | Published Date: Oct 2024 | No. of Page: 113 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
1 Study Coverage
    1.1 Biopharmaceutical Oral Drug Delivery Product Introduction
    1.2 Market by Type
        1.2.1 Global Biopharmaceutical Oral Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Normally Protein (Antibodies)
        1.2.3 Nucleic Acids (DNA, RNA Or Oligonucleotides)
    1.3 Market by Application
        1.3.1 Global Biopharmaceutical Oral Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Specialty Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Biopharmaceutical Oral Drug Delivery Sales Estimates and Forecasts 2017-2028
    2.2 Global Biopharmaceutical Oral Drug Delivery Revenue Estimates and Forecasts 2017-2028
    2.3 Global Biopharmaceutical Oral Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Biopharmaceutical Oral Drug Delivery Sales by Region
        2.4.1 Global Biopharmaceutical Oral Drug Delivery Sales by Region (2017-2022)
        2.4.2 Global Sales Biopharmaceutical Oral Drug Delivery by Region (2023-2028)
    2.5 Global Biopharmaceutical Oral Drug Delivery Revenue by Region
        2.5.1 Global Biopharmaceutical Oral Drug Delivery Revenue by Region (2017-2022)
        2.5.2 Global Biopharmaceutical Oral Drug Delivery Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Biopharmaceutical Oral Drug Delivery Sales by Manufacturers
        3.1.1 Global Top Biopharmaceutical Oral Drug Delivery Manufacturers by Sales (2017-2022)
        3.1.2 Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biopharmaceutical Oral Drug Delivery in 2021
    3.2 Global Biopharmaceutical Oral Drug Delivery Revenue by Manufacturers
        3.2.1 Global Biopharmaceutical Oral Drug Delivery Revenue by Manufacturers (2017-2022)
        3.2.2 Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Biopharmaceutical Oral Drug Delivery Revenue in 2021
    3.3 Global Biopharmaceutical Oral Drug Delivery Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Biopharmaceutical Oral Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Biopharmaceutical Oral Drug Delivery Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Biopharmaceutical Oral Drug Delivery Sales by Type
        4.1.1 Global Biopharmaceutical Oral Drug Delivery Historical Sales by Type (2017-2022)
        4.1.2 Global Biopharmaceutical Oral Drug Delivery Forecasted Sales by Type (2023-2028)
        4.1.3 Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2017-2028)
    4.2 Global Biopharmaceutical Oral Drug Delivery Revenue by Type
        4.2.1 Global Biopharmaceutical Oral Drug Delivery Historical Revenue by Type (2017-2022)
        4.2.2 Global Biopharmaceutical Oral Drug Delivery Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2017-2028)
    4.3 Global Biopharmaceutical Oral Drug Delivery Price by Type
        4.3.1 Global Biopharmaceutical Oral Drug Delivery Price by Type (2017-2022)
        4.3.2 Global Biopharmaceutical Oral Drug Delivery Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Biopharmaceutical Oral Drug Delivery Sales by Application
        5.1.1 Global Biopharmaceutical Oral Drug Delivery Historical Sales by Application (2017-2022)
        5.1.2 Global Biopharmaceutical Oral Drug Delivery Forecasted Sales by Application (2023-2028)
        5.1.3 Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2017-2028)
    5.2 Global Biopharmaceutical Oral Drug Delivery Revenue by Application
        5.2.1 Global Biopharmaceutical Oral Drug Delivery Historical Revenue by Application (2017-2022)
        5.2.2 Global Biopharmaceutical Oral Drug Delivery Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2017-2028)
    5.3 Global Biopharmaceutical Oral Drug Delivery Price by Application
        5.3.1 Global Biopharmaceutical Oral Drug Delivery Price by Application (2017-2022)
        5.3.2 Global Biopharmaceutical Oral Drug Delivery Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Biopharmaceutical Oral Drug Delivery Market Size by Type
        6.1.1 North America Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2028)
        6.1.2 North America Biopharmaceutical Oral Drug Delivery Revenue by Type (2017-2028)
    6.2 North America Biopharmaceutical Oral Drug Delivery Market Size by Application
        6.2.1 North America Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2028)
        6.2.2 North America Biopharmaceutical Oral Drug Delivery Revenue by Application (2017-2028)
    6.3 North America Biopharmaceutical Oral Drug Delivery Market Size by Country
        6.3.1 North America Biopharmaceutical Oral Drug Delivery Sales by Country (2017-2028)
        6.3.2 North America Biopharmaceutical Oral Drug Delivery Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Biopharmaceutical Oral Drug Delivery Market Size by Type
        7.1.1 Europe Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2028)
        7.1.2 Europe Biopharmaceutical Oral Drug Delivery Revenue by Type (2017-2028)
    7.2 Europe Biopharmaceutical Oral Drug Delivery Market Size by Application
        7.2.1 Europe Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2028)
        7.2.2 Europe Biopharmaceutical Oral Drug Delivery Revenue by Application (2017-2028)
    7.3 Europe Biopharmaceutical Oral Drug Delivery Market Size by Country
        7.3.1 Europe Biopharmaceutical Oral Drug Delivery Sales by Country (2017-2028)
        7.3.2 Europe Biopharmaceutical Oral Drug Delivery Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Biopharmaceutical Oral Drug Delivery Market Size by Type
        8.1.1 Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2028)
        8.1.2 Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Type (2017-2028)
    8.2 Asia Pacific Biopharmaceutical Oral Drug Delivery Market Size by Application
        8.2.1 Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2028)
        8.2.2 Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Application (2017-2028)
    8.3 Asia Pacific Biopharmaceutical Oral Drug Delivery Market Size by Region
        8.3.1 Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Region (2017-2028)
        8.3.2 Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Biopharmaceutical Oral Drug Delivery Market Size by Type
        9.1.1 Latin America Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2028)
        9.1.2 Latin America Biopharmaceutical Oral Drug Delivery Revenue by Type (2017-2028)
    9.2 Latin America Biopharmaceutical Oral Drug Delivery Market Size by Application
        9.2.1 Latin America Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2028)
        9.2.2 Latin America Biopharmaceutical Oral Drug Delivery Revenue by Application (2017-2028)
    9.3 Latin America Biopharmaceutical Oral Drug Delivery Market Size by Country
        9.3.1 Latin America Biopharmaceutical Oral Drug Delivery Sales by Country (2017-2028)
        9.3.2 Latin America Biopharmaceutical Oral Drug Delivery Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Biopharmaceutical Oral Drug Delivery Market Size by Type
        10.1.1 Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Type (2017-2028)
    10.2 Middle East and Africa Biopharmaceutical Oral Drug Delivery Market Size by Application
        10.2.1 Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Application (2017-2028)
    10.3 Middle East and Africa Biopharmaceutical Oral Drug Delivery Market Size by Country
        10.3.1 Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 AbbVie
        11.1.1 AbbVie Corporation Information
        11.1.2 AbbVie Overview
        11.1.3 AbbVie Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 AbbVie Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 AbbVie Recent Developments
    11.2 Amgen
        11.2.1 Amgen Corporation Information
        11.2.2 Amgen Overview
        11.2.3 Amgen Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Amgen Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Amgen Recent Developments
    11.3 Catalent
        11.3.1 Catalent Corporation Information
        11.3.2 Catalent Overview
        11.3.3 Catalent Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Catalent Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Catalent Recent Developments
    11.4 Kemwell Bipharma
        11.4.1 Kemwell Bipharma Corporation Information
        11.4.2 Kemwell Bipharma Overview
        11.4.3 Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Kemwell Bipharma Recent Developments
    11.5 Pfizer
        11.5.1 Pfizer Corporation Information
        11.5.2 Pfizer Overview
        11.5.3 Pfizer Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Pfizer Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Pfizer Recent Developments
    11.6 Novartis
        11.6.1 Novartis Corporation Information
        11.6.2 Novartis Overview
        11.6.3 Novartis Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Novartis Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Novartis Recent Developments
    11.7 Biocon
        11.7.1 Biocon Corporation Information
        11.7.2 Biocon Overview
        11.7.3 Biocon Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Biocon Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Biocon Recent Developments
    11.8 Sanofi
        11.8.1 Sanofi Corporation Information
        11.8.2 Sanofi Overview
        11.8.3 Sanofi Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Sanofi Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Sanofi Recent Developments
    11.9 F. Hoffman-La Roche
        11.9.1 F. Hoffman-La Roche Corporation Information
        11.9.2 F. Hoffman-La Roche Overview
        11.9.3 F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 F. Hoffman-La Roche Recent Developments
    11.10 Novo Nordisk
        11.10.1 Novo Nordisk Corporation Information
        11.10.2 Novo Nordisk Overview
        11.10.3 Novo Nordisk Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Novo Nordisk Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Novo Nordisk Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Biopharmaceutical Oral Drug Delivery Industry Chain Analysis
    12.2 Biopharmaceutical Oral Drug Delivery Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Biopharmaceutical Oral Drug Delivery Production Mode & Process
    12.4 Biopharmaceutical Oral Drug Delivery Sales and Marketing
        12.4.1 Biopharmaceutical Oral Drug Delivery Sales Channels
        12.4.2 Biopharmaceutical Oral Drug Delivery Distributors
    12.5 Biopharmaceutical Oral Drug Delivery Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Biopharmaceutical Oral Drug Delivery Industry Trends
    13.2 Biopharmaceutical Oral Drug Delivery Market Drivers
    13.3 Biopharmaceutical Oral Drug Delivery Market Challenges
    13.4 Biopharmaceutical Oral Drug Delivery Market Restraints
14 Key Findings in The Global Biopharmaceutical Oral Drug Delivery Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Biopharmaceutical Oral Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Normally Protein (Antibodies)
    Table 3. Major Manufacturers of Nucleic Acids (DNA, RNA Or Oligonucleotides)
    Table 4. Global Biopharmaceutical Oral Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Biopharmaceutical Oral Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Biopharmaceutical Oral Drug Delivery Sales by Region (2017-2022) & (K Units)
    Table 7. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Region (2017-2022)
    Table 8. Global Biopharmaceutical Oral Drug Delivery Sales by Region (2023-2028) & (K Units)
    Table 9. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Region (2023-2028)
    Table 10. Global Biopharmaceutical Oral Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Region (2017-2022)
    Table 12. Global Biopharmaceutical Oral Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Region (2023-2028)
    Table 14. Global Biopharmaceutical Oral Drug Delivery Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Biopharmaceutical Oral Drug Delivery Sales Share by Manufacturers (2017-2022)
    Table 16. Global Biopharmaceutical Oral Drug Delivery Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Biopharmaceutical Oral Drug Delivery Revenue Share by Manufacturers (2017-2022)
    Table 18. Biopharmaceutical Oral Drug Delivery Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Biopharmaceutical Oral Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Biopharmaceutical Oral Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Oral Drug Delivery as of 2021)
    Table 21. Biopharmaceutical Oral Drug Delivery Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Biopharmaceutical Oral Drug Delivery Product Offered
    Table 23. Date of Manufacturers Enter into Biopharmaceutical Oral Drug Delivery Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 26. Global Biopharmaceutical Oral Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 27. Global Biopharmaceutical Oral Drug Delivery Sales Share by Type (2017-2022)
    Table 28. Global Biopharmaceutical Oral Drug Delivery Sales Share by Type (2023-2028)
    Table 29. Global Biopharmaceutical Oral Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Biopharmaceutical Oral Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Biopharmaceutical Oral Drug Delivery Revenue Share by Type (2017-2022)
    Table 32. Global Biopharmaceutical Oral Drug Delivery Revenue Share by Type (2023-2028)
    Table 33. Biopharmaceutical Oral Drug Delivery Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Biopharmaceutical Oral Drug Delivery Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 36. Global Biopharmaceutical Oral Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 37. Global Biopharmaceutical Oral Drug Delivery Sales Share by Application (2017-2022)
    Table 38. Global Biopharmaceutical Oral Drug Delivery Sales Share by Application (2023-2028)
    Table 39. Global Biopharmaceutical Oral Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Biopharmaceutical Oral Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Biopharmaceutical Oral Drug Delivery Revenue Share by Application (2017-2022)
    Table 42. Global Biopharmaceutical Oral Drug Delivery Revenue Share by Application (2023-2028)
    Table 43. Biopharmaceutical Oral Drug Delivery Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Biopharmaceutical Oral Drug Delivery Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 46. North America Biopharmaceutical Oral Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 47. North America Biopharmaceutical Oral Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Biopharmaceutical Oral Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 50. North America Biopharmaceutical Oral Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 51. North America Biopharmaceutical Oral Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Biopharmaceutical Oral Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Biopharmaceutical Oral Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 54. North America Biopharmaceutical Oral Drug Delivery Sales by Country (2023-2028) & (K Units)
    Table 55. North America Biopharmaceutical Oral Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Biopharmaceutical Oral Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Biopharmaceutical Oral Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Biopharmaceutical Oral Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Biopharmaceutical Oral Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Biopharmaceutical Oral Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Biopharmaceutical Oral Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Biopharmaceutical Oral Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Biopharmaceutical Oral Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Biopharmaceutical Oral Drug Delivery Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Biopharmaceutical Oral Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Biopharmaceutical Oral Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Biopharmaceutical Oral Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Biopharmaceutical Oral Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Biopharmaceutical Oral Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Biopharmaceutical Oral Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Biopharmaceutical Oral Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Biopharmaceutical Oral Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Biopharmaceutical Oral Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Biopharmaceutical Oral Drug Delivery Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Biopharmaceutical Oral Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Biopharmaceutical Oral Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 105. AbbVie Corporation Information
    Table 106. AbbVie Description and Major Businesses
    Table 107. AbbVie Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. AbbVie Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. AbbVie Recent Developments
    Table 110. Amgen Corporation Information
    Table 111. Amgen Description and Major Businesses
    Table 112. Amgen Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Amgen Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Amgen Recent Developments
    Table 115. Catalent Corporation Information
    Table 116. Catalent Description and Major Businesses
    Table 117. Catalent Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Catalent Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Catalent Recent Developments
    Table 120. Kemwell Bipharma Corporation Information
    Table 121. Kemwell Bipharma Description and Major Businesses
    Table 122. Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Kemwell Bipharma Recent Developments
    Table 125. Pfizer Corporation Information
    Table 126. Pfizer Description and Major Businesses
    Table 127. Pfizer Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Pfizer Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Pfizer Recent Developments
    Table 130. Novartis Corporation Information
    Table 131. Novartis Description and Major Businesses
    Table 132. Novartis Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Novartis Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Novartis Recent Developments
    Table 135. Biocon Corporation Information
    Table 136. Biocon Description and Major Businesses
    Table 137. Biocon Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Biocon Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Biocon Recent Developments
    Table 140. Sanofi Corporation Information
    Table 141. Sanofi Description and Major Businesses
    Table 142. Sanofi Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Sanofi Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Sanofi Recent Developments
    Table 145. F. Hoffman-La Roche Corporation Information
    Table 146. F. Hoffman-La Roche Description and Major Businesses
    Table 147. F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. F. Hoffman-La Roche Recent Developments
    Table 150. Novo Nordisk Corporation Information
    Table 151. Novo Nordisk Description and Major Businesses
    Table 152. Novo Nordisk Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Novo Nordisk Biopharmaceutical Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Novo Nordisk Recent Developments
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Biopharmaceutical Oral Drug Delivery Distributors List
    Table 158. Biopharmaceutical Oral Drug Delivery Customers List
    Table 159. Biopharmaceutical Oral Drug Delivery Market Trends
    Table 160. Biopharmaceutical Oral Drug Delivery Market Drivers
    Table 161. Biopharmaceutical Oral Drug Delivery Market Challenges
    Table 162. Biopharmaceutical Oral Drug Delivery Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biopharmaceutical Oral Drug Delivery Product Picture
    Figure 3. Global Biopharmaceutical Oral Drug Delivery Market Share by Type in 2021 & 2028
    Figure 3. Normally Protein (Antibodies) Product Picture
    Figure 4. Nucleic Acids (DNA, RNA Or Oligonucleotides) Product Picture
    Figure 5. Global Biopharmaceutical Oral Drug Delivery Market Share by Application in 2021 & 2028
    Figure 6. Hospital Pharmacy
    Figure 7. Retail Pharmacy
    Figure 8. Specialty Pharmacy
    Figure 9. Biopharmaceutical Oral Drug Delivery Report Years Considered
    Figure 10. Global Biopharmaceutical Oral Drug Delivery Sales 2017-2028 (K Units)
    Figure 11. Global Biopharmaceutical Oral Drug Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Biopharmaceutical Oral Drug Delivery Revenue 2017-2028 (US$ Million)
    Figure 13. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Region (2017-2022)
    Figure 15. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Region (2023-2028)
    Figure 16. North America Biopharmaceutical Oral Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Biopharmaceutical Oral Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Biopharmaceutical Oral Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Biopharmaceutical Oral Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Biopharmaceutical Oral Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Biopharmaceutical Oral Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Biopharmaceutical Oral Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Biopharmaceutical Oral Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Biopharmaceutical Oral Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Biopharmaceutical Oral Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Biopharmaceutical Oral Drug Delivery Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Biopharmaceutical Oral Drug Delivery in the World: Market Share by Biopharmaceutical Oral Drug Delivery Revenue in 2021
    Figure 28. Global Biopharmaceutical Oral Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 30. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 31. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 32. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 33. North America Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 34. North America Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 35. North America Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 36. North America Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 37. North America Biopharmaceutical Oral Drug Delivery Sales Share by Country (2017-2028)
    Figure 38. North America Biopharmaceutical Oral Drug Delivery Revenue Share by Country (2017-2028)
    Figure 39. U.S. Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 42. Europe Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 44. Europe Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Biopharmaceutical Oral Drug Delivery Sales Share by Country (2017-2028)
    Figure 46. Europe Biopharmaceutical Oral Drug Delivery Revenue Share by Country (2017-2028)
    Figure 47. Germany Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 48. France Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue Share by Region (2017-2028)
    Figure 58. China Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 61. India Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Biopharmaceutical Oral Drug Delivery Sales Share by Country (2017-2028)
    Figure 73. Latin America Biopharmaceutical Oral Drug Delivery Revenue Share by Country (2017-2028)
    Figure 74. Mexico Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue Share by Country (2017-2028)
    Figure 83. Turkey Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Biopharmaceutical Oral Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 86. Biopharmaceutical Oral Drug Delivery Value Chain
    Figure 87. Biopharmaceutical Oral Drug Delivery Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Amgen
Catalent
Kemwell Bipharma
Pfizer
Novartis
Biocon
Sanofi
F. Hoffman-La Roche
Novo Nordisk
Frequently Asked Questions
Biopharmaceutical Oral Drug Delivery report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biopharmaceutical Oral Drug Delivery report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biopharmaceutical Oral Drug Delivery report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Clinical Mobility

Clinical Mobility market is segmented by players, region (country), by Type and by Application. P ... Read More